NCT06210126

Brief Summary

This study aims to compare the effect of pectointercostal fascial plane block (PIFB) on postoperative chronic pain in patients undergoing open heart surgery with the standard multimodal analgesia technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

January 18, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2025

Completed
Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

1.4 years

First QC Date

December 20, 2023

Last Update Submit

May 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • chronic pain

    Postoperative chronic pain will be evaluated using brief pain inventory at 3 months after cardiac surgery. Brief Pain Inventory is a questionnaire designed to capture both pain intensity and the amount of interference that pain has on functioning. Pain intensity is measured with four items (worst, least, on average, and currently). Interference is measured with seven items, including general activity, mood, walking, work (including paid and household work), relations with others, sleep, and enjoyment of life. The patient answers the items on a scale of 0-10, the highest number indicating the worst imaginable pain for intensity items and complete interference for interference items.

    3 months

Secondary Outcomes (5)

  • Time to extubation

    24 hour

  • Postoperative pain score

    72 hour

  • Postoperative nausea and vomiting (PONV)

    72 hour

  • Length of stay in the ICU

    7 day

  • The number of patients who required rescue analgesic

    72 hour

Study Arms (2)

Pectointercostal Fascial Plane Block Group

ACTIVE COMPARATOR

In addition to routine standard perioperative and postoperative analgesia protocol patients will receive bilateral local anesthetic injections at the Pectointercostal Fascial Plane Block

Other: local anesthetic injection

Control

OTHER

Patients will receive standard perioperative and postoperative analgesia protocol

Other: Standard perioperative and postoperative analgesia protocol

Interventions

Ultrasound-guided pectointercostal fascial plane block group using 20 mL of 0.25% bupivacaine

Pectointercostal Fascial Plane Block Group

postoperative IV morphine PCA and paracetamol will be given. If VAS is 3 or above, 75 mg dexketoprofen trometamol will be administered.

Control

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 3 risk score patients scheduled for elective open heart surgery

You may not qualify if:

  • Emergent surgery
  • Previous thoracotomy
  • LVEF \<30
  • Patients with psychiatric disorders
  • Presence of hematological disease
  • Patients with alcohol-drug addiction
  • Patients who use daily opioids for any reason
  • Chronic analgesic use
  • Allergy to local anesthetics
  • BMI \>40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Betul Kozanhan

Konya, 42005, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Chronic Pain

Interventions

Anesthetics, Local

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 18, 2024

Study Start

January 18, 2024

Primary Completion

May 28, 2025

Study Completion

May 28, 2025

Last Updated

May 29, 2025

Record last verified: 2025-05

Locations